References
- Lipsky J J. Mycophenolate mofetil. Lancet 1996; 348(9038)1357–1359, [PUBMED], [INFOTRIEVE]
- Allison A C, Eugui E M. Immunosuppressive and other effects of mycophenolic acid and an ester prodrug, mycophenolate mofetil. Immunol Rev 1993; 136: 5–28, [PUBMED], [INFOTRIEVE], [CSA]
- Mycophenolate mofetil–a new immunosuppressant for organ transplantation. Med Lett Drugs Ther 1995; 37(958)84–86, [CSA]
- Hood K A, Zarembski D G. Mycophenolate mofetil: a unique immunosuppressive agent. Am J Health‐Syst Pharm 1997; 54(3)285–294, [CSA]
- Chan T M, Li F K, Tang C S, Wong R W, Fang G X, Ji Y L, Lau C S, Wong A K, Tong M K, Chan K W, Lai K N. Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong‐Guangzhou nephrology study group. N Engl J Med 2000; 343(16)1156–1162, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Bullingham R E, Nicholls A J, Kamm B R. Clinical pharmacokinetics of mycophenolate mofetil. Clin Pharmacokinet 1998; 34(6)429–455, [PUBMED], [INFOTRIEVE], [CSA]
- Shaw L M, Sollinger H W, Halloran P, Morris R E, Yatscoff R W, Ransom J, Tsina I, Keown P, Holt D W, Lieberman R, et al. Mycophenolate mofetil: a report of the consensus panel. Ther Drug Monit 1995; 17(6)690–699, [PUBMED], [INFOTRIEVE], [CSA]
- Deierhoi M H, Kauffman R S, Hudson S L, Barber W H, Curtis J J, Julian B A, Gaston R S, Laskow D A, Diethelm A G. Experience with mycophenolate mofetil (RS61443) in renal transplantation at a single center. Ann Surg 1993; 217(5)476–482, discussion 482–4[PUBMED], [INFOTRIEVE]
- Placebo‐controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection. European mycophenolate mofetil cooperative study group. Lancet 1995; 345(8961)1321–1325
- Dooley M A, Cosio F G, Nachman P H, Falkenhain M E, Hogan S L, Falk R J, Hebert L A. Mycophenolate mofetil therapy in lupus nephritis: clinical observations. J Am Soc Nephrol 1999; 10(4)833–839, [PUBMED], [INFOTRIEVE], [CSA]